Evidence map›Paper›PMID 29621342›Full record

ArticlePloS one2018

A staphylococcal anti-sigma factor possesses a single-domain, carries different denaturant-sensitive regions and unfolds via two intermediates.

Debabrata Sinha, Rajkrishna Mondal, Avisek Mahapa, Keya Sau, Rajagopal Chattopadhyaya, Subrata Sau

Abstract read
In one paragraph

Article in PloS one, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Debabrata SinhaDepartment of Biochemistry, Bose Institute, Kolkata, West Bengal, India.
Rajkrishna MondalDepartment of Biotechnology, Nagaland University, Dimapur, Nagaland, India.
Avisek MahapaDepartment of Biotechnology, Haldia Institute of Technology, Haldia, West Bengal, India.
Keya SauDepartment of Biotechnology, Haldia Institute of Technology, Haldia, West Bengal, India.
Rajagopal ChattopadhyayaDepartment of Biochemistry, Bose Institute, Kolkata, West Bengal, India.
Subrata SauDepartment of Biochemistry, Bose Institute, Kolkata, West Bengal, India.ORCID 0000-0001-6197-0981

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

RsbW, an anti-sigma factor possessing kinase activity, is expressed by many Gram-positive bacteria including Staphylococcus aureus. To obtain clues about the domain structure and the folding-unfolding mechanism of RsbW, we have elaborately studied rRsbW, a recombinant S. aureus RsbW. Sequence analysis of the protein fragments, generated by the limited proteolysis of rRsbW, has proposed it to be a single-domain protein. The unfolding of rRsbW in the presence of GdnCl or urea was completely reversible in nature and occurred through the formation of at least two intermediates. The structure, shape, and the surface hydrophobicity of no intermediate completely matches with those of other intermediates or the native rRsbW. Interestingly, one of the intermediates, formed in the presence of less GdnCl concentrations, has a molten globule-like structure. Conversely, all of the intermediates, like native rRsbW, exist as dimers in aqueous solution. The putative molten globule and the urea-generated intermediates also have retained some kinase activity. Additionally, the putative ATP binding site/catalytic site of rRsbW shows higher denaturant sensitivity than the tentative dimerization region of this enzyme.

Indexed as

Amino Acid SequenceBacillus subtilisBacterial ProteinsBase SequenceCarrier ProteinsCatalytic DomainHydrophobic and Hydrophilic InteractionsSequence Analysis, DNASigma FactorStaphylococcus aureusBacterial ProteinsCarrier ProteinsRsbV protein, BacteriaRsbW protein, bacteriaSigma Factorspore-specific proteins, Bacillus

Identifiers

PMID29621342
PMCPMC5886543

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.